Results 41 to 50 of about 197,741 (365)

A randomised controlled trial and cost-effectiveness evaluation of "booster" interventions to sustain increases in physical activity in middle-aged adults in deprived urban neighbourhoods [PDF]

open access: yes, 2010
Background: Systematic reviews have identified a range of brief interventions which increase physical activity in previously sedentary people. There is an absence of evidence about whether follow up beyond three months can maintain long term physical ...
Daniel Hind   +62 more
core   +1 more source

Factors underlying COVID-19 booster vaccine uptake among fully vaccinated adults in Belgium

open access: yes, 2023
Background To tackle waning protection against severe COVID-19 infection, booster doses of the COVID-19 vaccines were recommended among individuals who received their primary course.
L. Catteau   +7 more
core   +1 more source

COVID Arm After Moderna Booster in Healthcare Worker: A Case Report

open access: yesActa Medica Indonesiana, 2021
SARS CoV-2 virus has infected more than 200 million people worldwide and more than 4.4 million in Indonesia. The vaccination program has become one of the solutions launched by many countries globally, including Indonesia, to reduce the transmission rate
Anshari Saifuddin   +5 more
doaj  

Humoral and Cellular Responses to BNT162b2 as a Booster Following Two Doses of ChAdOx1 nCov-19 Determined Using Three SARS-CoV-2 Antibody Assays and an Interferon-Gamma Release Assay: A Prospective Longitudinal Study in Healthcare Workers

open access: yesFrontiers in Immunology, 2022
Data on humoral and cellular responses to BNT162b2 as a booster dose, following two doses of ChAdOx1 nCov-19 vaccine, have seldom been reported. The aim of this study was to assess the positivity rates of three representative antibody assays targeting ...
Seri Jeong   +7 more
doaj   +1 more source

The Boosters in Boosterism: Some Calgary Examples [PDF]

open access: yesUrban History Review, 1979
Through an examination of four Calgary boosters in the pre-1914 period, this article argues that boosterism in the prairie west was largely institutional. The rhetoric of progress was proclaimed loudest in publications produced by business organizations and political bodies.
openaire   +1 more source

COVID-19 vaccine and booster hesitation around the world: A literature review

open access: yesFrontiers in Medicine, 2023
The development of COVID-19 vaccines has helped limit the extent of the pandemic, which over the past 2 years has claimed the lived of millions of people.
Aashka Shah, O. Coiado
semanticscholar   +1 more source

COVID-19 Incidence and Mortality Among Unvaccinated and Vaccinated Persons Aged ≥12 Years by Receipt of Bivalent Booster Doses and Time Since Vaccination — 24 U.S. Jurisdictions, October 3, 2021–December 24, 2022

open access: yesMMWR. Morbidity and mortality weekly report, 2023
On September 1, 2022, CDC recommended an updated (bivalent) COVID-19 vaccine booster to help restore waning protection conferred by previous vaccination and broaden protection against emerging variants for persons aged ≥12 years (subsequently extended to
DrPH Amelia G. Johnson   +65 more
semanticscholar   +1 more source

Article Hedges vs boosters: Communicative mitigation and enhancement in the genre of dissertation review [PDF]

open access: yesЖанры речи, 2023
The article presents the results of the cross-disciplinary research which focuses on the two types of discourse markers – hedges and boosters and their use in Russian official dissertation reviews.
Viktorova, Elena Yurievna
doaj   +1 more source

Safety and immunogenicity of aerosolised Ad5-nCoV, intramuscular Ad5-nCoV, or inactivated COVID-19 vaccine CoronaVac given as the second booster following three doses of CoronaVac: a multicentre, open-label, phase 4, randomised trial

open access: yesThe Lancet Respiratory Medicine, 2023
Background Aerosolised Ad5-nCoV is the first approved mucosal respiratory COVID-19 vaccine to be used as a booster after the primary immunisation with COVID-19 vaccines.
R. Tang   +25 more
semanticscholar   +1 more source

Effectiveness of mRNA COVID-19 vaccine booster doses against Omicron severe outcomes

open access: yesNature Communications, 2023
This study investigates the protection provided by mRNA COVID-19 vaccine booster doses against Omicron-associated severe disease in adults aged 50 and older. The authors use data from Ontario, Canada, and find that booster doses provide strong protection
R. Grewal   +12 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy